Wolverine Trading’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,000
| Closed | -$319K | – | 7123 |
|
|
2021
Q1 | $319K | Sell |
4,000
-11,400
| -74% | -$890K | ﹤0.01% | 4388 |
|
|
2020
Q4 | $1.21M | Buy |
+15,400
| New | +$903K | ﹤0.01% | 2186 |
|
|
2020
Q2 | – | Sell |
-7,800
| Closed | -$297K | – | 5521 |
|
|
2020
Q1 | $297K | Buy |
+7,800
| New | +$444K | ﹤0.01% | 3233 |
|
|
2019
Q4 | – | Sell |
-16,900
| Closed | -$1.27M | – | 5461 |
|
|
2019
Q3 | $1.27M | Buy |
16,900
+13,800
| +445% | +$1.17M | ﹤0.01% | 1783 |
|
|
2019
Q2 | $250K | Sell |
3,100
-2,100
| -40% | -$148K | ﹤0.01% | 3470 |
|
|
2019
Q1 | $348K | Buy |
+5,200
| New | +$394K | ﹤0.01% | 3187 |
|
|
2017
Q4 | – | Sell |
-15,000
| Closed | -$1.41M | – | 5752 |
|
|
2017
Q3 | $1.41M | Buy |
15,000
+3,200
| +27% | +$253K | 0.01% | 1598 |
|
|
2017
Q2 | $910K | Buy |
+11,800
| New | +$886K | ﹤0.01% | 1841 |
|
|
2017
Q1 | – | Sell |
-5,400
| Closed | -$425K | – | 5283 |
|
|
2016
Q4 | $425K | Buy |
5,400
+1,200
| +29% | +$93.2K | ﹤0.01% | 2828 |
|
|
2016
Q3 | $324K | Buy |
+4,200
| New | +$305K | ﹤0.01% | 3131 |
|
Wolverine Trading's CMD Position: Q2 2019 in Review
Wolverine Trading sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 5,694 shares — an estimated $400K sold.
Wolverine Trading first reported a position in CMD in Q4 2016 and held it in 3 quarters. The position peaked at $416K in Q3 2017. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.
- Wolverine Trading reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
- Wolverine Trading sold 5,694 Cantel Medical Corporation shares in Q2 2019, an estimated $400K.
- Wolverine Trading first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 3 quarters.
- Wolverine Trading's Cantel Medical Corporation position peaked at $416K in Q3 2017.
- 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.
Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.